“We ask the administration to consider establishing exemptions for pharmaceutical products and long implementation timelines ...

Nutriband (NTRB) announced that it has signed an addendum to the Commercial Development and Clinical Supply Agreement for its lead product, ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

New research - led by the University of Portsmouth in collaboration with the University of Southampton, King’s College London, and the Massachusetts Institute of Technology - has developed a set of ...

New standards including a three-month supply of medication to patients were discussed ... and improve the quality and delivery of that service. And that is being more direct, being more ...

Gawande also added that disruptions in the supply of medications create the risk of ... for all existing foreign aid and suspended the delivery of new aid. As a result, the USAID office in Ukraine ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria and tuberculosis, as well as medical supplies for newborn babies, in countries supported by USAID around ...

Our sure supply program is designed so that providers have reliable access to the medications they need ... depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products ...